We are live on ! Find out more
APGE icon

Apogee Therapeutics
APGE

139 hedge funds and large institutions have $3.29B invested in Apogee Therapeutics in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more funds holding in top 10

Funds holding in top 10: 4 → 7 (+3)

55% more capital invested

Capital invested by funds: $2.13B → $3.29B (+$1.16B)

4.24% more ownership

Funds ownership: 120.42% → 124.65% (+4.2%)

4% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 46

0% more funds holding

Funds holding: 139 → 139 (0)

0% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 25

83% less call options, than puts

Call options by funds: $2.65M | Put options by funds: $15.2M

Holders
139
Holders Change
–
Holders Change %
0%
% of All Funds
2%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.1%
New
25
Increased
48
Reduced
46
Closed
25
Calls
$2.65M
Puts
$15.2M
Net Calls
-$12.6M
Net Calls Change
-$12M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$60.7M
2
WCA
Waypoint Capital Advisors
Minnesota
+$30M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$22M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$21M
5
DCM
Driehaus Capital Management
Illinois
+$19.9M

Top Sellers

1
B
Braidwell
Connecticut
-$35.9M
2
APM
Avidity Partners Management
Texas
-$16M
3
DM
Deerfield Management
New York
-$12.9M
4
FTM
First Turn Management
California
-$12.5M
5
PCH
Polar Capital Holdings
United Kingdom
-$9.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
WTA
126
Washington Trust Advisors
Massachusetts
$5.64K – – –
RTL
127
Red Tortoise LLC
Georgia
$5.52K – – –
SCM
128
Sterling Capital Management
North Carolina
$2.17K +$1.77K +37 New
BAM
129
Bellevue Asset Management
Washington
$2.11K – – –
RIL
130
Rothschild Investment LLC
Illinois
$2.06K +$958 +20 +133%
Carson Wealth (CWM LLC)
131
Carson Wealth (CWM LLC)
Nebraska
$2K +$1.15K +24 +240%
Bessemer Group
132
Bessemer Group
New Jersey
$2K +$1.44K +30 New
Simplex Trading
133
Simplex Trading
Illinois
$2K +$1.82K +38 New
GI
134
GAMMA Investing
California
$1.88K +$1.01K +21 +191%
Osaic Holdings
135
Osaic Holdings
Arizona
$1.53K -$190K -3,956 -99%
Credit Agricole
136
Credit Agricole
France
$1.21K +$98.6K +2,057 New
CPA
137
Capital Performance Advisors
California
$764 +$623 +13 New
PA
138
Parallel Advisors
California
$646 +$527 +11 New
DM
139
Deerfield Management
New York
– -$12.9M -329,000 Closed
FTM
140
First Turn Management
California
– -$12.5M -318,327 Closed
PCH
141
Polar Capital Holdings
United Kingdom
– -$9.84M -250,000 Closed
Renaissance Technologies
142
Renaissance Technologies
New York
– -$6.15M -156,204 Closed
Citadel Advisors
143
Citadel Advisors
Florida
– -$5.57M -116,318 Closed
TI
144
Trexquant Investment
Connecticut
– -$3.43M -87,201 Closed
IHAM
145
Integral Health Asset Management
New York
– -$3.15M -80,000 Closed
SCM
146
Sio Capital Management
New York
– -$3.07M -78,000 Closed
AGP
147
Artia Global Partners
Florida
– -$2.3M -58,400 Closed
Adage Capital Partners
148
Adage Capital Partners
Massachusetts
– -$1.97M -50,000 Closed
JF
149
Jump Financial
Illinois
– -$1.71M -43,458 Closed
SCM
150
Superstring Capital Management
New York
– -$1.45M -36,928 Closed
3 4 5
6
7

APGE Hedge Fund Activity: Q3 2024 in Review

139 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Apogee Therapeutics (APGE) for Q3 2024, worth a combined $3.29B — up 55% from $2.13B a quarter earlier.

Fund positioning in APGE was balanced in Q3 2024: 25 funds opened new positions, 25 closed out, 48 added to existing stakes and 46 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $60.7M. The largest seller was Braidwell, cutting an estimated $35.9M.

  • 139 institutional investors held Apogee Therapeutics (APGE) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $3.29B of Apogee Therapeutics stock for Q3 2024, up 55% quarter-over-quarter.
  • 25 funds opened new Apogee Therapeutics positions in Q3 2024 and 25 closed out, a net change of 0 holders.
  • The largest Apogee Therapeutics buyer in Q3 2024 was Wellington Management Group, an estimated $60.7M added.
  • The largest Apogee Therapeutics seller in Q3 2024 was Braidwell, an estimated $35.9M sold.

Based on aggregated 13F filings for Q3 2024.